Indications
Therapeutic Asset Ratings
3,272 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Atezolizumab
Alveolar Soft Part Sarcoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Enteropathy-Associated T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Hepatosplenic T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Neoplasm Of Mature T-Cells Or NK-Cells
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Subcutaneous Panniculitis-Like T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Azacitidine
Nasopharyngeal Squamous Cell Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Azacitidine
Undifferentiated Carcinoma Of Nasopharynx
National Cancer Institute (NCI)
P1
CC
(43)
Azenosertib
Gastric Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Azenosertib
Gastroesophageal Junction Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Azenosertib
Gastric Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Azenosertib
Gastric Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Aztreonam
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Belinostat
B-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Belinostat
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
National Cancer Institute (NCI)
P1
CC
(43)
Berzosertib
Bilateral Breast Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Berzosertib
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Berzosertib
Breast Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Berzosertib
Colorectal Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Berzosertib
Lung Neuroendocrine Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Berzosertib
Metastatic Malignant Neoplasm In The Brain
National Cancer Institute (NCI)
P1
CC
(43)
Berzosertib
Exocrine Pancreatic Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Berzosertib
Ovarian Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Berzosertib
Ovarian Serous Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Showing 2701 to 2725 of 3,272 assets
Previous
Page 109 of 131
Next
